We assessed morbidity and mortality among Thai and Vietnamese adolescents and young adults with perinatally acquired human immunodeficiency virus (PHIV) compared with matched HIV-negative peers, 12–24 years of age. Data on serious adverse events (SAEs) were prospectively collected between 2013 and 2018 according to U.S. NIH Division of AIDS criteria. Of 288 youth, 142 had PHIV and 146 were HIV negative. At enrollment, the overall median age was 19 (interquartile range [IQR] 17–20) years, 67% were female, and 95% were Thai. Almost all PHIV youth (99%) were receiving antiretroviral therapy; 50% self-reported adherence ≥95%. Median CD4 was 579 (IQR 404–800) cells/mm3, and 24% had HIV-RNA ≥1,000 copies/mL. During follow-up, 31 (22%) PHIV youth and 9 (6%) HIV-negative youth had at least one SAE. The overall crude SAE rate was 4.66 (3.42–6.35) per 100 person-years (PY); 7.22 (5.08–10.26) per 100 PY among youth with PHIV and 2.10 (1.09–4.03) per 100 PY in HIV-negative youth (p < .001). All seven deaths that occurred were among those with PHIV and primarily due to opportunistic infections (e.g., pneumocystis pneumonia, tuberculous meningitis). In multivariate analyses, having PHIV, being <20 years of age, and having anogenital high-risk human papillomavirus (HPV) infection with types 16 and/or 18 increased risk of SAEs. Among PHIV youth, CD4 count <350 cells/mm3, HIV-RNA ≥1,000 copies/mL, advanced WHO stages, and having anogenital HPV 16 and/or 18 infection predicted higher incidence of SAEs; no prior use of alcohol was protective. These data emphasize the need for tailored interventions for adolescents with PHIV to prevent long-term morbidity and mortality.
Get full access to this article
View all access options for this article.
References
1.
AIDSinfo: Global Data on HIV Epidemiology and Response [Internet]. UNAIDS; 2021. Available from: https://aidsinfo.unaids.org/ [Last accessed: July 28, 2021].
2.
UNICEF. Turning the Tide Against AIDS Will Require More Concentrated Focus on Adolescents and Young People. 2021. Available from: https://data.unicef.org/topic/hivaids/adolescents-young-people/ [Last accessed: January 31, 2020].
3.
KimSH, GerverSM, FidlerS, et al.Adherence to antiretroviral therapy in adolescents living with HIV: Systematic review and meta-analysis. AIDS, 2014; 28(13):1945–1956.
4.
AgwuAL, FairlieL. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc, 2013; 16:18579.
5.
DesmondeS, NeilanAM, MusickB, et al.Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. J Int AIDS Soc, 2020; 23(10):e25617.
6.
NeilanAM, KaraliusB, PatelK, et al.Association of risk of viremia, immunosuppression, serious clinical events, and mortality with increasing age in perinatally human immunodeficiency virus-infected youth. JAMA Pediatr, 2017; 171(5):450–460.
7.
HaasAD, TechnauKG, PahadS, et al.Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa. J Int AIDS Soc, 2020; 23(12):e25644.
8.
JuddA, LodwickR, Noguera-JulianA, et al.Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med, 2017; 18(3):171–180.
9.
WeijsenfeldAM, SmitC, CohenS, et al.Virological and social outcomes of HIV-infected adolescents and young adults in The Netherlands before and after transition to adult care. Clin Infect Dis, 2016; 63(8):1105–1112.
10.
RiceBD, DelpechVC, ChadbornTR, et al.Loss to follow-up among adults attending human immunodeficiency virus services in England, Wales, and Northern Ireland. Sex Transm Dis, 2011; 38(8):685–690.
11.
FishR, JuddA, JungmannE, et al.Mortality in perinatally HIV-infected young people in England following transition to adult care: An HIV Young Persons Network (HYPNet) audit. HIV Med, 2014; 15(4):239–244.
12.
UNAIDS. AIDS by the Numbers. 2015. Available from: https://www.unaids.org/sites/default/files/media_asset/AIDS_by_the_numbers_2015_en.pdf
13.
SohnAH, HazraR. Old problems for new providers: Managing the postpediatric HIV generation. Clin Infect Dis, 2017; 64(8):1113–1114.
14.
AurpibulL, SophonphanJ, MaleeK, et al.HIV-related enacted stigma and increase frequency of depressive symptoms among Thai and Cambodian adolescents and young adults with perinatal HIV. Int J STD AIDS, 2021; 32(3):246–256.
15.
PhanuphakN, TeeraananchaiS, HansudewechakulR, et al.Incidence and persistence of high-risk anogenital human papillomavirus infection among female youth with and without perinatally acquired human immunodefiency virus infection: A 3-year observational cohort study. Clin Infect Dis, 2020; 71(8):e270–e280.
16.
BartlettAW, MohamedTJ, SudjaritrukT, et al.Disease- and treatment-related morbidity in adolescents with perinatal HIV infection in Asia. Pediatr Infect Dis J, 2019; 38(3):287–292.
17.
SohnAH, ChokephaibulkitK, LumbiganonP, et al.Peritransition outcomes of southeast asian adolescents and young adults with HIV transferring from pediatric to adult care. J Adolesc Health, 2020; 66(1):92–99.
18.
JacobsonDL, NeriD, GaskinsA, et al.Maternal anemia and preterm birth among women living with HIV in the United States. Am J Clin Nutr, 2021; 113(6):1402–1410.
19.
AngrandRC, SperlingR, RoccobonoK, et al.Depression in perinatally HIV-infected pregnant women compared to non-perinatally HIV-infected and HIV-uninfected pregnant women. AIDS Care, 2018; 30(9):1168–1172.
20.
SohnAH, KerrSJ, HansudewechakulR, et al.Risk factors for human papillomavirus infection and abnormal cervical cytology among perinatally human immunodeficiency virus-infected and uninfected Asian Youth. Clin Infect Dis, 2018; 67(4):606–613.
21.
WittawatmongkolO, GatechompolS, KerrSJ, et al.Human papillomavirus infection among male adolescents and young adults with perinatally-acquired HIV and without HIV in Thailand. Int J STD AIDS, 2019; 30(10):960–968.
22.
RossJL, TeeraananchaiS, LumbiganonP, et al.A longitudinal study of behavioral risk, adherence, and virologic control in adolescents living with HIV in Asia. J Acquir Immune Defic Syndr, 2019; 81(2):e28–e38.
23.
Division of AIDSNIoAaID, National Institutes of HealthU.S. Department of Health and Human Services. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events. Corrected Version 2.1; July 2017.
24.
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord; JuddA, et al.Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study. PLoS Med, 2018; 15(1):e1002491.
25.
TraisathitP, DeloryT, Ngo-Giang-HuongN, et al.AIDS-defining events and deaths in HIV-infected children and adolescents on antiretrovirals: A 14-year study in Thailand. J Acquir Immune Defic Syndr, 2018; 77(1):17–22.
26.
BerrySA, GeboKA, RutsteinRM, et al.Trends in hospitalizations among children and young adults with perinatally acquired HIV. Pediatr Infect Dis J, 2014; 33(5):488–494.
27.
KourtisAP, BansilP, PosnerSF, et al.Trends in hospitalizations of HIV-infected children and adolescents in the United States: Analysis of data from the 1994–2003 Nationwide Inpatient Sample. Pediatrics, 2007; 120(2):e236–e243.
28.
CasaleM, CarlqvistA, CluverL. Recent interventions to improve retention in HIV care and adherence to antiretroviral treatment among adolescents and youth: A systematic review. AIDS Patient Care STDS, 2019; 33(6):237–252.
29.
ReifLK, AbramsEJ, ArpadiS, et al.Interventions to improve antiretroviral therapy adherence among adolescents and youth in low- and middle-income countries: A systematic review 2015–2019. AIDS Behav, 2020; 24(10):2797–2810.
30.
KimMH, MazengaAC, YuX, et al.High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: Barriers and associated factors. J Int AIDS Soc, 2017; 20(1):21437.
31.
SitholeZ, MbizvoE, ChonziP, et al.Virological failure among adolescents on ART, Harare City, 2017—A case-control study. BMC Infect Dis, 2018; 18(1):469.
32.
DoLA, BoonmongkonP, PaekSC, et al.‘Hu Hong’ (bad thing): Parental perceptions of teenagers' sexuality in urban Vietnam. BMC Public Health, 2017; 17(1):226.
33.
SettheekulS, FongkaewW, ViseskulN, et al.Factors influencing sexual risk behaviors among adolescents: A community-based participatory study. Nurs Health Sci, 2019; 21(2):186–197.
34.
LowenthalED, Bakeera-KitakaS, MarukutiraT, et al.Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: A review of emerging challenges. Lancet Infect Dis, 2014; 14(7):627–639.
35.
BaileyH, CruzMLS, SongtaweesinWN, et al.Adolescents with HIV and transition to adult care in the Caribbean, Central America and South America, Eastern Europe and Asia and Pacific regions. J Int AIDS Soc, 2017; 20(Suppl 3):21475.
36.
SanjeevaGN, SahanaM, PavithraHB, et al.Transition of children with perinatally acquired HIV-infection into adulthood: Social outcome and quality of life. Indian J Pediatr, 2019; 86(3):233–240.
37.
TothG, MburuG, TuotS, et al.Social-support needs among adolescents living with HIV in transition from pediatric to adult care in Cambodia: Findings from a cross-sectional study. AIDS Res Ther, 2018; 15(1):8.
38.
KhozaN, StadlerJ, MacPhailC, et al.Cash transfer interventions for sexual health: Meanings and experiences of adolescent males and females in inner-city Johannesburg. BMC Public Health, 2018; 18(1):120.
39.
KehoeK, BoulleA, TsondaiPR, et al.Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: A longitudinal analysis. J Int AIDS Soc, 2020; 23(5):e25476.
40.
MavhuW, WillisN, MufukaJ, et al.Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): A cluster-randomised controlled trial. Lancet Glob Health, 2020; 8(2):e264–e275.
41.
CluverL, PantelicM, ToskaE, et al.STACKing the odds for adolescent survival: Health service factors associated with full retention in care and adherence amongst adolescents living with HIV in South Africa. J Int AIDS Soc, 2018; 21(9):e25176.
42.
VreemanRC, RakhmaninaNY, NyandikoWM, et al.Are we there yet? 40years of successes and challenges for children and adolescents living with HIV. J Int AIDS Soc, 2021; 24(6):e25759.
43.
HansudewechakulR, PongprapassS, KongphonoiA, et al.Transition of Thai HIV-infected adolescents to adult HIV care. J Int AIDS Soc, 2015; 18:20651.
44.
ChokephaibulkitK, TarugsaJ, LolekhaR, et al.Outcomes of a comprehensive youth program for HIV-infected adolescents in Thailand. J Assoc Nurses AIDS Care, 2015; 26(6):758–769.
45.
LolekhaR, Boon-YasidhiV, Na-NakornY, et al.The Happy Teen programme: A holistic outpatient clinic-based approach to prepare HIV-infected youth for the transition from paediatric to adult medical care services in Thailand. J Int AIDS Soc, 2017; 20(Suppl 3):21500.
46.
TeeraananchaiS, KerrSJ, GandhiM, et al.Determinants of viral resuppression or persistent virologic failure after initial failure with second-line antiretroviral treatment among Asian children and adolescents with HIV. J Pediatric Infect Dis Soc, 2020; 9(2):253–256.
47.
TeeraananchaiS, KerrSJ, RuxrungthamK, et al.Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand. Antivir Ther, 2018; 23(6):529–538.
48.
BartlettAW, SudjaritrukT, MohamedTJ, et al.Identification, management and outcomes of combination antiretroviral treatment failure in adolescents with perinatal HIV infection in Asia. Clin Infect Dis, 2021; 73(7):e1919–e1926.
49.
SohnAH, LumbiganonP, KurniatiN, et al.Determining standardized causes of death of infants, children, and adolescents living with HIV in Asia. AIDS, 2020; 34(10):1527–1537.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
